Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Grows By 38.0%

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 273,700 shares, an increase of 38.0% from the August 31st total of 198,300 shares. Currently, 2.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,630,000 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, LADENBURG THALM/SH SH began coverage on shares of Autonomix Medical in a report on Tuesday, September 3rd. They issued a “buy” rating and a $1.40 price target on the stock.

Autonomix Medical Stock Performance

Shares of AMIX traded up $0.01 during midday trading on Friday, hitting $0.60. The stock had a trading volume of 31,618 shares, compared to its average volume of 1,849,576. The stock’s 50 day moving average is $0.79 and its 200 day moving average is $1.73. The company has a current ratio of 9.27, a quick ratio of 9.27 and a debt-to-equity ratio of 0.20. Autonomix Medical has a 1 year low of $0.51 and a 1 year high of $7.60.

Autonomix Medical (NASDAQ:AMIX) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. Research analysts anticipate that Autonomix Medical will post -0.5 earnings per share for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.